Wu Z, Berlemann LA, Bader V, Sehr DA, Dawin E, Covallero A, Meschede J, Angersbach L, Showkat C, Michaelis JB, Münch C, Rieger B, Namgaladze D, Herrera MG, Fiesel FC, Springer W, Mendes M, Stepien J, Barkovits K, Marcus K, Sickmann A, Dittmar G, Busch KB, Riedel D, Brini M, Tatzelt J, Cali T, Winklhofer KF (2022) LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus. EMBO J. 2022 Dec 15;41(24): e112006. doi: 10.15252/embj.2022112006
Junghans M, John F, Cihankaya H, Schliebs D, Winklhofer KF, Bader V, Matschke J, Theiss C, Matschke V (2022) ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice in vitro. Front Cell Neurosci. 2022 Aug 31;16: 963169. doi: 10.3389/fncel.2022.963169
Meister TL, Brüggemann Y, Nocke MK, Ulrich RG, Schuhenn J, Sutter K, Gömer A, Bader V, Winklhofer KF, Broering R, Verhoye L, Meuleman P, Vondran FWR, Camuzet C, Cocquerel L, Todt D, Steinmann E (2022) A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function. Proc Natl Acad Sci U S A. 2022 Aug 23;119(34): e2202653119. doi: 10.1073/pnas.2202653119
Mueller-Buehl C, Reinhard J, Roll L, Bader V, Winklhofer KF, Faissner A (2022) Brevican, Neurocan, Tenascin-C, and Tenascin-R Act as Important Regulators of the Interplay Between Perineuronal Nets, Synaptic Integrity, Inhibitory Interneurons, and Otx2. Front Cell Dev Biol. 2022 Jun 2;10:886527. doi: 10.3389/fcell.2022.886527
Krause LJ, Herrera MG, Winklhofer KF (2022) The Role of Ubiquitin in Regulating Stress Granule Dynamics. Front Physiol. 2022 May 25; 13:910759. doi: 10.3389/fphys.2022.910759
Stein J, Walkenfort B, Cihankaya H, Hasenberg M, Bader V, Winklhofer KF, Röderer P, Matschke J, Theiss C, Matschke V (2021) Increased ROS-Dependent Fission of Mitochondria Causes Abnormal Morphology of the Cell Powerhouses in a Murine Model of Amyotrophic Lateral Sclerosis. Oxid Med Cell Longev. 2021 Oct 14;2021:6924251. doi: 10.1155/2021/6924251
Schlagowski AM, Knöringer K, Morlot S, Sánchez Vicente A, Flohr T, Krämer L, Boos F, Khalid N, Ahmed S, Schramm J, Murschall LM, Haberkant P, Stein F, Riemer J, Westermann B, Braun RJ, Winklhofer KF, Charvin G, Herrmann JM (2021) Increased levels of mitochondrial import factor Mia40 prevent the aggregation of polyQ proteins in the cytosol. EMBO J. 2021 Aug 16;40(16):e107913. doi: 10.15252/embj.2021107913
Oliva R, Mukherjee SK, Ostermeier L, Pazurek LA, Kriegler S, Bader V, Prumbaum D, Raunser S, Winklhofer KF, Tatzelt J, Winter RHA (2021) Remodeling of the Fibrillation Pathway of α-Synuclein by Interaction with Antimicrobial Peptide LL-III. Chemistry 2021 Aug 16;27(46):11845-11851. doi: 10.1002/chem.202101592
Kamps J, Lin YH, Oliva R, Bader V, Winter R, Winklhofer KF, Tatzelt J (2021) The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain. J Biol Chem. 2021 Jul;297(1): 100860. doi.: 10.1016/j.jbc.2021.100860
Ulfig A, Bader V, Varatnitskaya M, Lupilov N, Winklhofer KF, Leichert LI (2021) Hypochlorous acid-modified human serum albumin suppresses MHC class II - dependent antigen presentation in pro-inflammatory macrophages. Redox Biol. 2021 Jul:43:101981. doi: 10.1016/j.redox.2021.101981
Lei L, Wu Z, Winklhofer KF (2021) Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separation. Matrix Biol. 2021 Jun:100-101:9-22. doi: 10.1016/j.matbio.2020.11.003
Ingles-Prieto A, Furthmann N, Crossman SH, Tichy AM, Hoyer N, Petersen M, Zheden V, Biebl J, Reichhart E, Gyoergy A, Siekhaus DE, Soba P, Winklhofer KF, Janovjak H (2021) Optogenetic delivery of trophic signals in a genetic model of Parkinson's disease. PLoS Genet. 2021 Apr 15;17(4):e1009479. doi: 10.1371/journal.pgen.1009479
Marks D, Heinen N, Bachmann L, Meermeyer S, Werner M, Gallego L, Hemmerich P, Bader V, Winklhofer KF, Schröder E, Knauer SK, Müller T (2021) Amyloid precursor protein elevates fusion of promyelocytic leukemia nuclear bodies in human hippocampal areas with high plaque load. Acta Neuropathol Commun. 2021 Apr 13;9(1):66. doi: 10.1186/s40478-021-01174-x
Ahlers J, Adams EM, Bader V, Pezzotti S, Winklhofer KF, Tatzelt J, Havenith M (2021) The key role of solvent in condensation: mapping water in liquid-liquid phase-separated FUS. Biophys J. 2021 Apr 6;120(7):1266-1275. doi: 10.1016/j.bpj.2021.01.019
Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, Gerstein S, Del Mare-Roumani S, Amidror S, Staszewski O, Poschmann G, Stühler K, Hirche F, Balogh A, Kempa S, Träger P, Zaiss MM, Holm JB, Massa MG, Nielsen HB, Faissner A, Lukas C, Gatermann SG, Scholz M, Przuntek H, Prinz M, Forslund SK, Winklhofer KF, Müller DN, Linker RA, Gold R, Haghikia A (2020) Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. 2020 Mar 19;180(6):1067-1080.e16. doi: 10.1016/j.cell.2020.02.035
Bader V, Winklhofer KF (2020) Mitochondria at the interface between neurodegeneration and neuroinflammation. Semin Cell Dev Biol. 2020 Mar:99, 163-171. doi: 10.1016/j.semcdb.2019.05.028
Meschede J, Šadić M, Furthmann N, Miedema T, Sehr DA, Müller-Rischart AK, Bader V, Berlemann LA, Pilsl A, Schlierf A, Barkovits K, Kachholz B, Rittinger K, Ikeda F, Marcus K, Schaefer L, Tatzelt J, Winklhofer KF (2020) The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC. Sci Signal. 2020 Feb 4;13(617):eaav1256. doi: 10.1126/scisignal.aav1256
Dittmar G, Winklhofer KF (2020) Linear Ubiquitin Chains: Cellular Functions and Strategies for Detection and Quantification. Front Chem. 2020 Jan 10;7:915. doi: 10.3389/fchem.2019.00915
Xie K, Varatnitskaya M, Maghnouj A, Bader V, Winklhofer KF, Hahn S, Leichert LI (2020) Activation leads to a significant shift in the intracellular redox homeostasis of neutrophil-like cells. Redox Biol. 2020 Jan:28:101344. doi: 10.1016/j.redox.2019.101344
Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM (2019) α-Synuclein in Parkinson's disease: causal or bystander? J. Neural Transm (Vienna). 126(7): 815-840. doi: 10.1007/s00702-019-02025-9
Ceballos J, Schwalfenberg M, Karageorgis G, Reckzeh ES, Sievers S, Ostermann C, Pahl A, Sellstedt M, Nowacki J, Carnero Corrales MA, Wilke J, Laraia L, Tschapalda K, Metz M, Sehr DA, Brand S, Winklhofer KF, Janning P, Ziegler S, Waldmann H (2019) Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3. Angew Chem Int Ed Engl. 58(47): 17016-17025 doi: 10.1002/anie.201909518
van Well EM, Bader V, Patra M, Sánchez-Vicente A, Meschede J, Furthmann N, Schnack C, Blusch A, Longworth J, Petrasch-Parwez E, Mori K, Arzberger T, Trümbach D, Angersbach L, Showkat C, Sehr DA, Berlemann LA, Goldmann P, Clement AM, Behl C, Woerner AC, Saft C, Wurst W, Haass C, Ellrichmann G, Gold R, Dittmar G, Hipp MS, Hartl FU, Tatzelt J, Winklhofer KF (2019) A protein quality control pathway regulated by linear ubiquitination. EMBO J. 38(9): e100730. doi: 10.15252/embj.2018100730
Ellrichmann G, Blusch A, Fatoba O, Brunner J, Reick C, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R (2019) Author Correction: Laquinimod treatment in the R6/2 mouse model. Sci Rep. 9(1): 4960. doi: 10.1038/s41598-018-37926-4
Engelke AD, Gonsberg A, Thapa S, Jung S, Ulbrich S, Seidel R, Basu S, Multhaup G, Baier M, Engelhard M, Schätzl HM, Winklhofer KF, Tatzelt J (2018) Dimerization of the cellular prion protein inhibits propagation of scrapie prions. J Biol Chem. 293(21): 8020-8031. doi: 10.1074/jbc.RA117.000990
Röderer P, Klatt L, John F, Theis V, Winklhofer KF, Theiss C, Matschke V (2018) Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation. Mol Neurobiol. 55(11): 8414-8424. doi: 10.1007/s12035-018-0999-7
Degrossoli A, Müller A, Xie K, Schneider JF, Bader V, Winklhofer KF, Meyer AJ, Leichert LI (2018) Neutrophil-generated HOCl leads to non-specific thiol oxidation in phagocytized bacteria. Elife 7. pii: e32288. doi: 10.7554/eLife.32288
Ellrichmann G, Blusch A, Fatoba O, Brunner J, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R (2017) Laquinimod treatment in the R6/2 mouse model. Sci Rep. 7(1): 4947. doi: 10.1038/s41598-017-04990-1
Menges S, Minakaki G, Schaefer PM, Meixner H, Prots I, Schlötzer-Schrehardt U, Friedland K, Winner B, Outeiro TF, Winklhofer KF, von Arnim CA, Xiang W, Winkler J, Klucken J (2017) Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Sci Rep. 7: 42942. doi: 10.1038/srep42942
Bruch J, Xu H, Rösler TW, De Andrade A, Kuhn PH, Lichtenthaler SF, Arzberger T, Winklhofer KF, Müller U, Höglinger GU (2017) PERK activation mitigates tau pathology in vitro and in vivo. EMBO Mol Med. 9(3): 371-384. doi: 10.15252/emmm.201606664
Klionsky DJ et al. (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12(1): 1-222. doi: 10.1080/15548627.2015.1100356
Woerner AC, Frottin F, Hornburg D, Feng LR, Meissner F, Patra M, Tatzelt J, Mann M, Winklhofer KF, Hartl FU and Hipp MS (2016) Cytoplasmic protein aggregates interfere with nucleo-cytoplasmic transport of protein and RNA. Science 351(6269): 173-176,. doi: 10.1126/science.aad2033
Klein P, Müller-Rischart AK, Motori E, Schönbauer C, Schnorrer F, Winklhofer KF and Klein R (2014) Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants. EMBO J 33(4): 341-355. doi: 10.1002/embj.201284290
Rolland SG, Motori E, Memar N, Hench J, Frank S, Winklhofer KF and Conradt B (2013) Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion. Proc Natl Acad Sci USA 110(32): E2967-E2976. doi: 10.1073/pnas.1303872110
Dirndorfer D, Seidel RP, Nimrod G, Miesbauer M, Ben-Tal N, Engelhard M, Zimmermann R, Winklhofer KF and Tatzelt J (2013) The α-helical structure of prodomains promotes translocation of intrinsically disordered neuropeptide hormones into the endoplasmic reticulum. J Biol Chem 288(20): 13961-13973. doi: 10.1074/jbc.M112.430264
Zhang L, Karsten P, Hamm S, Pogson JH, Müller-Rischart AK, Exner N, Haass C, Whitworth A, Winklhofer KF, Schulz JB and Voigt A (2013) TRAP1 rescues PINK1 loss-of-function phenotypes. Hum Mol Genet 22(14): 2829-2841. doi: 10.1093/hmg/ddt132
Pfeiffer NV, Dirndorfer D, Lang S, Miesbauer M, Zimmermann R, Winklhofer KF and Tatzelt J (2013) Structural features within the nascent chain regulate alternative targeting of secretory proteins to mitochondria. EMBO J 32(7): 1036-1051. doi: 10.1038/emboj.2013.46
Müller-Rischart AK, Pilsl A, Beaudette P, Hadian K, Deinlein A, Funke M, Patra M, Motori E, Schweimer C, Kuhn PH, Hrelia S, Lichtenthaler SF, Wurst W, Trümbach D, Langer T, Krappmann D, Dittmar G, Tatzelt, J and Winklhofer KF (2013) The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell 49(5): 908-921. doi: 10.1016/j.molcel.2013.01.036
Butler EK, Voigt A, Lutz AK, Toegel JP, Gerhardt E, Karsten P, Falkenburger B, Reinartz A, Winklhofer KF, Schulz JB. (2012) The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. PLoS Genet. 8(2): e1002488. doi: 10.1371/journal.pgen.1002488
Resenberger UK, Winklhofer KF, Tatzelt J. (2012) Cellular prion protein mediates toxic signaling of amyloid beta. Neurodegener Dis. 10(1-4): 298-300. doi: 10.1159/000332596
Pilsl A, Winklhofer KF (2012) Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease. Acta Neuropathol. 123(2): 173-88. doi: 10.1007/s00401-011-0902-3
Glasl L, Kloos K, Giesert F, Roethig A, Di Benedetto B, Kühn R, Zhang J, Hafen U, Zerle J, Hofmann A, de Angelis MH, Winklhofer KF, Hölter SM, Vogt Weisenhorn DM, Wurst W. (2012) Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Exp Neurol. 2012 May;235(1):214-27. doi: 10.1016/j.expneurol.2012.01.002
Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Multhaup G, Winklhofer KF, Tatzelt J (2011) The cellular prion protein mediates neurotoxic signaling of β-sheet-rich conformers independent of prion replication. EMBO J. 30(10): 2057-70. doi: 10.1038/emboj.2011.86
Sakthivelu V, Seidel RP, Winklhofer KF, Tatzelt J. (2011) Conserved stress-protective activity between prion protein and Shadoo. J Biol Chem. 286(11): 8901-8. doi: 10.1074/jbc.M110.185470
Bouman L, Schlierf A, Lutz AK, Shan J, Deinlein A, Kast J, Galehdar Z, Palmisano V, Patenge N, Berg D, Gasser T, Augustin R, Trümbach D, Irrcher I, Park DS, Wurst W, Kilberg MS, Tatzelt J, Winklhofer KF (2011) Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 18(5): 769-82. doi: 10.1038/cdd.2010.142
Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, Haass C (2010) Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29(20): 3571-89. doi: 10.1038/emboj.2010.223
Fett ME, Pilsl A, Paquet D, van Bebber F, Haass C, Tatzelt J, Schmid B, Winklhofer KF (2010) Parkin is protective against proteotoxic stress in a transgenic zebrafish model. PLoS One. 5(7): e11783. doi: 10.1371/journal.pone.0011783
Irrcher I, Aleyasin H, Seifert EL, Hewitt SJ, Chhabra S, Phillips M, Lutz AK, Rousseaux MW, Bevilacqua L, Jahani-Asl A, Callaghan S, MacLaurin JG, Winklhofer KF, Rizzu P, Rippstein P, Kim RH, Chen CX, Fon EA, Slack RS, Harper ME, McBride HM, Mak TW, Park DS. (2010) Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet. 19(19): 3734-46. doi: 10.1093/hmg/ddq288
Schumacher MC, Resenberger U, Seidel RP, Becker CF, Winklhofer KF, Oesterhelt D, Tatzelt J, Engelhard M (2010) Synthesis of a GPI anchor module suitable for protein post-translational modification. Biopolymers. 94(4): 457-64. doi: 10.1002/bip.21380
Miesbauer M, Rambold AS, Winklhofer KF, Tatzelt J. (2010) Targeting of the prion protein to the cytosol: mechanisms and consequences. Curr Issues Mol Biol. 12(2): 109-18. PMID: 19767654
Winklhofer KF, Haass C. (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta. 1802(1): 29-44. doi: 10.1016/j.bbadis.2009.08.013
Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lämmermann K, Brunner B, Kurz-Drexler A, Vogel F, Reichert AS, Bouman L, Vogt-Weisenhorn D, Wurst W, Tatzelt J, Haass C, Winklhofer KF (2009) Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284(34): 22938-51. doi: 10.1074/jbc.M109.035774
Rambold AS, Müller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J. (2008) Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J. 27(14): 1974-84. doi: 10.1038/emboj.2008.122
Schlehe JS, Lutz AK, Pilsl A, Lämmermann K, Grgur K, Henn IH, Tatzelt J, Winklhofer KF (2008) Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation. J Biol Chem. 283(20): 13771-9. doi: 10.1074/jbc.M707494200
Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J. 27(2): 336-49. doi: 10.1038/sj.emboj.7601930
Wegmann S, Miesbauer M, Winklhofer KF, Tatzelt J, Muller DJ (2008) Observing fibrillar assemblies on scrapie-infected cells. Pflugers Arch. 456(1): 83-93. doi: 10.1007/s00424-007-0433-x
Exner N, Treske B, Paquet D, Holmström K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Krüger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci. 27(45): 12413-8. doi: 10.1523/jneurosci.0719-07.2007
Olschewski D, Seidel R, Miesbauer M, Rambold AS, Oesterhelt D, Winklhofer KF, Tatzelt J, Engelhard M, Becker CF (2007) Semisynthetic murine prion protein equipped with a GPI anchor mimic incorporates into cellular membranes. Chem Biol. 14(9): 994-1006. doi: 10.1016/j.chembiol.2007.08.007
Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, Tatzelt J, Winklhofer KF (2007) Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci. 27(8): 1868-78. doi: 10.1523/jneurosci.5537-06.2007
Rambold AS, Miesbauer M, Rapaport D, Bartke T, Baier M, Winklhofer KF, Tatzelt J (2006) Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell. 17(8): 3356-68. doi: 10.1091/mbc.e06-01-0083
Winklhofer KF, Tatzelt J (2006) The role of chaperones in Parkinson's disease and prion diseases. Handb Exp Pharmacol. (172): 221-58. doi: 10.1007/3-540-29717-0_10
Hirschberger T, Stork M, Schropp B, Winklhofer KF, Tatzelt J, Tavan P (2006) Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations. Biophys J. 90(11): 3908-18. doi: 10.1529/biophysj.105.075341
Miesbauer M, Bamme T, Riemer C, Oidtmann B, Winklhofer KF, Baier M, Tatzelt J (2006) Prion protein-related proteins from zebrafish are complex glycosylated and contain a glycosylphosphatidylinositol anchor. Biochem Biophys Res Commun. 341(1): 218-24. doi: 10.1016/j.bbrc.2005.12.168
Bertsch U, Winklhofer KF, Hirschberger T, Bieschke J, Weber P, Hartl FU, Tavan P, Tatzelt J, Kretzschmar HA, Giese A (2005) Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J Virol. 79(12): 7785-91. doi: 10.1128/jvi.79.12.7785-7791.2005
Uelhoff A, Tatzelt J, Aguzzi A, Winklhofer KF, Haass C (2005) A pathogenic PrP mutation and doppel interfere with polarized sorting of the prion protein. J Biol Chem. 280(7): 5137-40. doi: 10.1074/jbc.C400560200
Henn IH, Gostner JM, Lackner P, Tatzelt J, Winklhofer KF (2005) Pathogenic mutations inactivate parkin by distinct mechanisms. J Neurochem. 92(1): 114-22. doi: 10.1111/j.1471-4159.2004.02854.x
Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J (2005) Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem. 280(10): 9320-9. doi: 10.1074/jbc.M412525200
Kiachopoulos S, Heske J, Tatzelt J, Winklhofer KF (2004) Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic. 5(6): 426-36. doi: 10.1111/j.1398-9219.2004.00185.x
Heske J, Heller U, Winklhofer KF, Tatzelt J (2004) The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem. 279(7): 5435-43. doi: 10.1074/jbc.M309570200
Brychzy A, Rein T, Winklhofer KF, Hartl FU, Young JC, Obermann WM (2003) Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system. EMBO J. 22(14): 3613-23. doi: 10.1093/emboj/cdg362
Heller U, Winklhofer KF, Heske J, Reintjes A, Tatzelt J (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem. 278(38): 36139-47. doi: 10.1074/jbc.M304002200
Winklhofer KF, Heller U, Reintjes A, Tatzelt J (2003) Inhibition of complex glycosylation increases the formation of PrPsc. Traffic. 4(5): 313-22. doi: 10.1034/j.1600-0854.2003.00088.x
Winklhofer KF, Heske J, Heller U, Reintjes A, Muranyi W, Moarefi I, Tatzelt J (2003) Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation. J Biol Chem. 278(17): 14961-70. doi: 10.1074/jbc.M209942200
Winklhofer KF, Hartl FU, Tatzelt J (2001) A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett. 503(1): 41-5. doi: 10.1016/s0014-5793(01)02692-8
Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J, Schätzl HM (2001) Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J. 20(15): 3957-66. doi: 10.1093/emboj/20.15.3957
Winklhofer KF, Tatzelt J (2000) Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells. Biol Chem. 381(5-6): 463-9. doi: 10.1515/BC.2000.061